Literature DB >> 33343260

Safety of Psychotropic Medications in People With COVID-19: Evidence Review and Practical Recommendations.

Giovanni Ostuzzi, Davide Papola, Chiara Gastaldon, Georgios Schoretsanitis, Federico Bertolini, Francesco Amaddeo, Alessandro Cuomo, Robin Emsley, Andrea Fagiolini, Giuseppe Imperadore, Taishiro Kishimoto, Giulia Michencigh, Michela Nosé, Marianna Purgato, Dursun Serdar, Brendon Stubbs, David Taylor, Graham Thornicroft, Philip B Ward, Christoph Hiemke, Christoph U Correll, Corrado Barbui.   

Abstract

(Reprinted with permission from the BMC Medicine (2020) 18:215).
Copyright © 2020 by the American Psychiatric Association.

Entities:  

Year:  2020        PMID： 33343260      PMCID： PMC7725161          DOI： 10.1176/appi.focus.18308

Source DB:  PubMed          Journal:  Focus (Am Psychiatr Publ)        ISSN： 1541-4094


  3 in total

1.  Potential Psychotropic and COVID-19 Drug Interactions: A Comparison of Integrated Evidence From Six Database Programs.

Authors:  Javedh Shareef; Sathvik Belagodu Sridhar; Sabin Thomas; Atiqulla Shariff; Sriharsha Chalasani
Journal:  Cureus       Date:  2021-12-10

2.  Delirium in COVID-19: An Atypical Case Managed With Quetiapine.

Authors:  Mark Laurence Silva; Owais Gul; Vamsi Priya Aravally; Maria Khalid; Tad Williams
Journal:  Cureus       Date:  2022-06-09

3.  Delirium in COVID-19 patients: a multicentric observational study in Italy.

Authors:  Giovanni Martinotti; Laura Bonanni; Stefano Barlati; Andrea Miuli; Gianna Sepede; Davide Prestia; Alice Trabucco; Claudia Palumbo; Alessandra Massaro; Martina Olcese; Damiano D'Ardes; Francesco Cipollone; Mario Amore; Emi Bondi; Mirella Russo; Claudia Carrarini; Marco Onofrj; Stefano Luca Sensi; Antonio Vita; Massimo di Giannantonio
Journal:  Neurol Sci       Date:  2021-07-28       Impact factor: 3.307
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.